| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▲ | 1.80▲ | 1.79▲ | 1.79▲ | 2.00▼ |
| MA10 | 1.80▲ | 1.79▲ | 1.79▲ | 1.96▼ | 1.92▼ |
| MA20 | 1.80▲ | 1.79▲ | 1.79▲ | 2.00▼ | 1.38▲ |
| MA50 | 1.79▲ | 1.77▲ | 1.85▼ | 1.84▼ | 1.11▲ |
| MA100 | 1.79▲ | 1.87▼ | 2.02▼ | 1.32▲ | 2.81▼ |
| MA200 | 1.79▲ | 2.03▼ | 1.95▼ | 1.03▲ | 10.26▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.002▲ | 0.009▲ | -0.059▼ | 0.071▲ |
| RSI | 60.666▲ | 56.597▲ | 52.945▲ | 47.074▼ | 57.512▲ |
| STOCH | 45.238 | 60.185 | 42.593 | 15.848▼ | 63.686 |
| WILL %R | 0.000▲ | -22.222▲ | -22.222▲ | -78.750▼ | -32.812 |
| CCI | 134.343▲ | 81.826 | 98.353 | -79.696 | 29.013 |
| CDL | $PALI Doji Candlestick Pattern Detected | Set Alert |
|
Thursday, December 04, 2025 02:30 AM
(GLOBE NEWSWIRE) -- (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company advancing next-generation, once daily, oral PDE4 inhibitor prodrugs for patients with ...
|
|
Tuesday, December 02, 2025 05:51 AM
Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, ...
|
|
Friday, November 21, 2025 02:34 AM
If you want to know who really controls Palisade Bio, Inc. (NASDAQ:PALI), then you'll have to look at the makeup of its share registry. And the group that holds the biggest piece of the pie are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/12/25 | 1.805 | 1.84 | 1.75 | 1.82 | 2,673,117 |
| 05/12/25 | 1.81 | 1.8284 | 1.75 | 1.80 | 2,175,770 |
| 04/12/25 | 1.73 | 1.86 | 1.69 | 1.80 | 6,569,828 |
| 03/12/25 | 1.83 | 1.83 | 1.65 | 1.69 | 6,963,800 |
| 02/12/25 | 1.88 | 1.93 | 1.70 | 1.83 | 4,977,000 |
| 01/12/25 | 2.07 | 2.07 | 1.85 | 1.87 | 4,574,000 |
| 28/11/25 | 2.16 | 2.255 | 2.085 | 2.11 | 2,546,659 |
| 26/11/25 | 2.17 | 2.29 | 2.00 | 2.23 | 4,191,900 |
| 25/11/25 | 2.28 | 2.31 | 2.13 | 2.15 | 2,069,096 |
| 24/11/25 | 2.15 | 2.32 | 2.13 | 2.28 | 3,328,900 |
|
|
||||
|
|
||||
|
|